Avedro Inc

AmberGen Inc., based in Watertown, MA, specializes in next-generation spatial biology through its innovative Miralys technology, which enhances mass spectrometry imaging capabilities. The company's patented solutions enable researchers to explore a wide array of biomolecules, including proteins, lipids, and small molecules, all within the same tissue sample for comprehensive multiomic analysis. With services provided through their MaxOmic Laboratory, AmberGen offers advanced imaging and analysis techniques that facilitate the investigation of diseases by generating deep biological insights swiftly. Their Miralys product line, which includes probes, panels, and antibody conjugation kits, is designed to empower researchers and drug developers in tackling significant questions in biology and medicine. Generated from the website

Genosco, a Boston-based clinical stage biotech, specializes in discovering and developing novel kinase inhibitors to address unmet medical needs. Their experienced team focuses on kinase targeted therapies, leveraging the proprietary G-SMART™ platform to identify rare sequences and generate highly selective compounds swiftly. With a strong and diverse pipeline, including independent and partnered programs, Genosco boasts a proven track record supported by successful out-licensing partnerships. The G-SMART™ Platform stands out for mapping over 470 ATP binding sites of human kinases and maintaining a chemical library of 3,500+ master scaffolds for predictive modeling. Unified under a shared vision to enhance patients' quality of life, Genosco emphasizes strengthening their discovery platform through cutting-edge science. CEO John Koh advocates for fostering an open and positive work environment where employees can unleash their creativity fully, ensuring continued innovation in the field of kinase inhibitors. Generated from the website content

BioAgilytix is a leading bioanalytical laboratory with state-of-the-art facilities in key biotech hubs across the United States, Europe, and Australia. Specializing in large molecule bioanalysis, they offer premier services that support all phases of drug development, from discovery to clinical trials. Their advanced laboratories combine specialized expertise, cutting-edge technology, and deep regulatory knowledge to accelerate global clinical studies. With a focus on delivering high-quality bioanalytical and diagnostic testing services, BioAgilytix is dedicated to enabling the breakthroughs of tomorrow today.Generated from the website